4d Pharma PLC Annual Report and Notice of AGM (9414D)
May 03 2017 - 2:00AM
UK Regulatory
TIDMDDDD
RNS Number : 9414D
4d Pharma PLC
03 May 2017
4D pharma plc
(the "Company" or "4D")
Annual Report and Notice of AGM
4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on
the development of live biotherapeutics, announces that the Annual
Report and Accounts for the year to 31 December 2016 and Notice of
the Company's Annual General Meeting ("AGM") have been posted to
shareholders.
An electronic copy of each of the Annual Report and Accounts and
the Notice of AGM is available on the Company's website,
www.4dpharmaplc.com.
The AGM will be held on Friday 26 May 2017 at 1 p.m. at the
Gridiron Building, 1 Pancras Square, London N1C 4AG.
For further information please contact:
4D + 44 (0)113 895 0130
Duncan Peyton, Chief Executive Officer
Zeus Capital Limited - Nomad and Joint Broker
Dan Bate +44 (0) 161 831 1512
Dominic Wilson +44 (0) 203 829 5000
Investec Bank plc - Joint Broker +44 (0) 207 597 5970
Patrick Robb
Daniel Adams
Carlton Nelson
About 4D
Founded in February 2014, 4D is a world leader in the
development of Live Biotherapeutics, a novel and emerging class of
drugs, defined by the FDA as biological products that contain a
live organism, such as a bacteria, that is applicable to the
prevention, treatment or cure of a disease. 4D has developed a
proprietary platform, MicroRx, that rationally identifies novel
bacteria that have a precise and evolved therapeutic effect. All of
4D's live biotherapeutic products are orally delivered single
strains of bacteria that are naturally found in the healthy human
gut. 4D currently has a pipeline of 13 preclinical programmes,
covering disease areas such as Rheumatoid Arthritis, Multiple
Sclerosis and cancer, and is currently conducting subject trials in
Irritable Bowel Syndrome and Paediatric Crohn's Disease. The
programmes in Paediatric Ulcerative Colitis and Paediatric Crohn's
Disease have both been granted Orphan Drug Status by the FDA.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFFSERIFIID
(END) Dow Jones Newswires
May 03, 2017 02:00 ET (06:00 GMT)
4d Pharma (LSE:DDDD)
Historical Stock Chart
From Apr 2024 to May 2024
4d Pharma (LSE:DDDD)
Historical Stock Chart
From May 2023 to May 2024